Literature DB >> 2839086

Effect of vasoactive intestinal peptide in man.

G J Krejs1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839086     DOI: 10.1111/j.1749-6632.1988.tb27003.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  4 in total

1.  Vasoactive intestinal polypeptide-augmented insulin release: actions on ionic fluxes and electrical activity of mouse islets.

Authors:  M A Wahl; S G Straub; H P Ammon
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

2.  Primary Pancreatic Secretinoma: Further Evidence Supporting Secretin as a Diarrheogenic Hormone.

Authors:  William Y Chey; Wendy L Frankel; Sashwati Roy; Soma Datta; Chandan K Sen; Mary Dillhoff; Peter Muscarella; Konrad H Soergel; Ronald K Tompkins; Ta-Min Chang; Edward L Bradley; Edwin Christopher Ellison
Journal:  Ann Surg       Date:  2017-08       Impact factor: 12.969

3.  Clinical-Pathological Conference Series from the Medical University of Graz : Case No 173: A 77-year-old patient with adenocarcinoma of the prostate, liver metastases and watery diarrhea.

Authors:  Elisabeth Fabian; Patrizia Kump; Dietmar Schiller; Iva Brcic; Christine Gruber; Philipp U Heitz; Günter Klöppel; Rainer W Lipp; Farid Moinfar; Rainer Schöfl; Peter Fickert; Guenter J Krejs
Journal:  Wien Klin Wochenschr       Date:  2021-01-04       Impact factor: 1.704

Review 4.  Therapeutic potential of vasoactive intestinal peptide and its receptor VPAC2 in type 2 diabetes.

Authors:  Xintong Hou; Dan Yang; Guimei Yang; Mengnan Li; Jian Zhang; Jiaxin Zhang; Yi Zhang; Yunfeng Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-20       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.